Positive impact on lives and healthcare budgets.
Podimetrics is bringing new hope to patients, payors and providers. View our favorite highlights below or see all our clinical evidence.
Reduced Complications and Amputations
In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:
Patient Experience and Adherence
In two different studies:
engaged at one year2
SmartMat “easy to use”3
Reduced Complications and Amputations
In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:
52% relative risk reduction1
† Net difference was observed despite 1.6 additional podiatry outpatient visits per-participant year resulting from inflammation detected by the study device.
Cost Savings and ROI
Podimetrics calculates up to $13,000 in annual cost savings per patient4
3.6X – 5.2X
$9,800 – 14,000
Choose innovation.
Not complications and amputations.
Learn MoreWhat's new at Podimetrics?
All NewsTackling Diabetic Amputations: How to Address SDoH for Patients
Diabetic amputations can be a heart-wrenching complication of diabetes. Their devastating effects extend not only to patients, but also to…One Person’s Fight to Prevent Amputation Due to Diabetes | Podimetrics
Every 3 minutes and 30 seconds in the United States, a limb is amputated because of diabetes. More alarmingly, 85%…Preventive Care: 500 pairs of shoes, 1 message
Once a mesmerizing ballroom dancer, Maria G. wowed crowds with her effortless poise and nimble footwork. But complex diabetes ended…
Tackling Diabetic Amputations: How to Address SDoH for Patients
Diabetic amputations can be a heart-wrenching complication of diabetes. Their devastating effects extend not only to patients, but also to…
1. Isaac, et al. BMJ Open Diab Res Care 2020
2. Rothenberg, et al. Fed Pract. 2020
3. Frykberg, et al. Diabetes Care 2017
4. Podimetrics Data on File
5. Assumptions based on 90 weeks of Intermountain Health claims data for 428 at-risk patients and applying results from our recent peer-reviewed study with Kaiser Permanente in the British Journal of Medicine (BMJ)